FinalDose

Pre-Seed
finaldose.ai AI & Machine Learning Oxford, United Kingdom 5 employees
Total Funding $500K
Latest Round Undisclosed Pre-Seed
Last Announced Jun 16, 2026
Investors 1 Backer
Decision Makers Profile Active

About FinalDose

FinalDose develops programmable DNA therapeutics that eliminate diseased cells by targeting pathogenic genetic sequences.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Pre-Seed
Global Headquarters Oxford, United Kingdom
Team Size 5 employees
Tracked Since Sep 28, 2026

Web & Domain Identity

Official Website finaldose.ai
Domain Registered Date Oct 20, 2025

Social & Network Presence

X / Twitter Profile @FinalDoseLFG (38 followers) Created on Oct 2025
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Pre-Seed announced

  2. Milestone

    X account created (@FinalDoseLFG)

    38 followers

  3. Milestone

    Website domain registered

    finaldose.ai

Investors & Backers

1
Y Combinator

Funding History

2 Rounds
Pre-Seed · Jun 16, 2026
Undisclosed
Venture Round · Undisclosed
$500,000 Source

Founders & Leadership

3

Jeff Liu

CEO & Co-Founder

Work email & phone locked Unlock →

Liyao Huang

CSO & Co-Founder

Work email & phone locked Unlock →

Steven Lin

CTO & Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts